Telsey Advisory lowered the firm’s price target on Bath & Body Works to $38 from $43 and keeps an Outperform rating on the shares. The firm believes the company is building a stronger foundation that will drive incremental growth and profitability in the long term, the analyst tells investors. Telsey reduces its price target on the stock due to continued tariff pressure.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target lowered to $41 from $43 at Morgan Stanley
- Positive Outlook for Bath & Body Works Amid Market Positioning and Growth Potential
- Bath & Body Works price target lowered to $40 from $45 at BofA
- Positive Outlook for Bath & Body Works Driven by Strategic Leadership and Innovation
- Buy Rating for Bath & Body Works: Promising Sales Growth and Strategic Innovation Amid Tariff Challenges